Overview
Financials
Revenue history
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 405 days for 2022).
- 2024not filed
- 202323/08/2024
- 202223/08/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mateusz Hreśkaage 30 | 20 | $540.25 | 33.3333% |
Ewelina Barbara Pawłowskaage 41 | 20 | $540.25 | 33.3333% |
Anna Beata Zamysłowskaage 26 | 20 | $540.25 | 33.3333% |
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
The articles of association place no restrictions on share transfers.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Centrum Medyczne MedicosS.A. | $4,714,965.98 | cmmedicos.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com |
FAQ
Last updated: 2026-10-03